2020 annual financial data
Nektar Therapeutics 2020 Net margin
Direct answer
Net margin was -290.65%.
Operating income was -379,922,000 USD and net income was -444,440,000 USD.
Operating cash flow was -313,287,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,915,000 USD
- Operating income
- -379,922,000 USD
- Net income
- -444,440,000 USD
- Operating cash flow
- -313,287,000 USD